Guide to Custom Peptide Synthesis: How to Obtain High-Quality Peptide Products?

Peptides have been widely used in drug discovery, biomedical research, antibody development, proteomics, cell-based experiments, and the development of cosmetic raw materials, among other fields. For most researchers, custom peptides have become an important part of routine experimental work. However, custom peptide synthesis is not simply a matter of submitting an amino acid sequence. Sequence length, purity grade, order quantity, terminal modifications, special labels, cyclization strategies, and unnatural amino acids all affect synthesis difficulty, purification methods, delivery timelines, and final pricing. This article introduces the key parameters that should be considered when ordering custom peptide synthesis, helping you obtain higher-quality peptide products.

Step 1: Determine the Peptide Sequence

The most essential information for a custom peptide is the amino acid sequence. When submitting a sequence, it is recommended to use the standard single-letter code, such as YGGFL or AEYLRQKVEGPPAA. This format facilitates rapid identification of the amino acid composition and also helps reduce ambiguity in communication. If the sequence contains unnatural amino acids, terminal modifications, or special labels, they should be clearly indicated in the sequence. For example, Ac-AEYLRQKVEGPPAA-NH2 indicates N-terminal acetylation and C-terminal amidation, while AEY[Aib]RQKVEGPPAA indicates the introduction of an unnatural amino acid such as Aib at the specified position. Accurate sequence information is the basis for quotation and production.

Step 2: Determine the Peptide Purity Requirement

Purity is one of the important factors affecting price and delivery time. Common purity grades include crude product, 75%, 80%, 90%, 95%, and above 98%. Different experiments have different purity requirements, so it should not be assumed simply that higher purity is always better. For general cell-based experiments, antigen peptide screening, or preliminary functional validation, 95% purity can usually meet the requirements. For drug discovery, analytical standards, structural studies, or experiments that are highly sensitive to impurities, purity above 98% is generally recommended. It should be noted that the higher the purity, the greater the purification difficulty, and the production cost will increase accordingly.

Step 3: Determine the Order Quantity

The order quantity should be determined based on the experimental stage and use case. Common specifications include 1 mg, 5 mg, 10 mg, 50 mg, 100 mg, and gram-scale or larger preparations. For early-stage experimental screening, 1–10 mg is usually sufficient to meet requirements. If the project enters functional validation, animal experiments, or method development, then 50 mg, 100 mg, or even larger-scale preparation may be needed. Subsequent functional validation or animal experiments may require larger-scale preparation. Planning experimental needs in advance helps reduce overall costs.

Step 4: Determine Terminal Modifications

Terminal modifications can affect peptide stability, biological activity, and in vivo behavior. The most common N-terminal modifications include Acetyl (Ac-), FITC, Biotin, and various fluorescent dyes. For the C-terminus, the Amide (-NH2) or Free Acid (-OH) form is usually selected. For example, Ac-AEYLRQKVEGPPAA-NH2 is a very common form used in experiments. N-terminal acetylation and C-terminal amidation can mimic the local environment in natural protein fragments and are also commonly used to improve peptide stability.

Step 5: Determine Special Modification Requirements

Special modifications are being used increasingly in modern peptide research and development.

Fluorescent Labeling

Fluorescent labeling is commonly used for cell imaging, localization experiments, and binding analysis. Common dyes include FITC, FAM, TAMRA, Cy3, and Cy5. Different dyes have different excitation wavelengths, emission wavelengths, hydrophobicity, and stability, so selection should be made in combination with the experimental platform and detection conditions.

Biotin Labeling

Biotin modification is widely used in Pull-down experiments, ELISA, and SPR analysis. Because Biotin and Streptavidin have very strong binding affinity, biotinylated peptides are commonly used for capture, immobilization, and interaction studies.

Phosphorylated Peptides

Phosphorylated peptides are commonly used in signaling pathway research. Common forms include pSer, pThr, and pTyr. Because phosphorylation modifications change the charge and hydrophilicity of peptides, these peptides usually require more careful method design during synthesis and purification.

Stable Isotope Labeling

Stable isotope-labeled peptides are mainly used for proteomics and quantitative mass spectrometry analysis. Common methods include 13C labeling, 15N labeling, and deuterium labeling. For quantitative mass spectrometry experiments, the labeling sites, isotope purity, and consistency of mass spectrometric response all need to be confirmed in advance.

Step 6: Is Cyclic Peptide Design Needed?

Cyclic peptides are one of the fastest-growing areas in peptide development in recent years. Compared with linear peptides, cyclic peptides usually have better stability, stronger protease resistance, higher binding selectivity, and longer in vivo half-lives. Cyclization can restrict the conformational freedom of a peptide, making it easier for the molecule to maintain a spatial configuration favorable for target binding. Common cyclization methods include Head-to-Tail cyclization, disulfide bond cyclization, Lactam cyclization, and Side Chain-to-Side Chain cyclization. Different cyclization methods have different effects on sequence design, reaction conditions, and final conformation. If a cyclization plan is already available, it is recommended to clearly state it when requesting a quotation. If the cyclization strategy has not yet been determined, a professional team can also assist with the design.

Step 7: Application of Unnatural Amino Acids

Unnatural amino acids (UAA) have become important tools in modern peptide optimization. Common unnatural amino acids include Aib, N-methyl amino acids, D-amino acids, Orn, Cit, Nal, Bip, and Cha. Rational introduction of these structural units can improve peptide stability, enhance activity, improve selectivity, and optimize in vivo pharmacokinetic properties. It should be noted that the introduction of unnatural amino acids may also increase the difficulty of synthesis and purification. Therefore, during the design stage, functional requirements, synthetic feasibility, and project budget should be considered comprehensively.

AI-Assisted Peptide Design

With the development of artificial intelligence technology, AI has begun to participate in the peptide design process. Based on sequence analysis and structure prediction, AI can assist with stability assessment, solubility prediction, aggregation risk analysis, cyclization site design, unnatural amino acid optimization, and activity optimization recommendations. AI tools can help researchers complete preliminary screening before entering the experimental stage, thereby improving R&D efficiency.

Conclusion

A successful peptide project depends not only on the amino acid sequence itself, but is also influenced by many factors, including purity, modification methods, cyclization strategy, selection of unnatural amino acids, and preparation scale. When submitting a request for quotation, providing complete project requirement information as much as possible not only enables a more accurate quotation, but also helps improve the project success rate and delivery quality. For complex projects, such as cyclic peptides, modified peptides, stable isotope-labeled peptides, and unnatural amino acid peptides, it is recommended to communicate thoroughly with a professional team at the project initiation stage in order to obtain the best solution.